Recruiting
Phase 2

Testosterone Replacement

Sponsor:

Seattle Institute for Biomedical and Clinical Research

Code:

NCT04049331

Conditions

Hypogonadism, Male

Fatigue Syndrome, Chronic

Eligibility Criteria

Sex: Male

Age: 18 - 54

Healthy Volunteers: Not accepted

Interventions

Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED]

placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Seattle Institute for Biomedical and Clinical Research on 2025-03-11.